medical benefit

Aetna, the health, medical and benefits insurance unit of CVS Health, has now secured the targeted $250 million of health care related reinsurance from its new Vitality Re XVII Ltd (Series 2026) catastrophe bond, pricing all three tranches at the top of initial guidance or above.

We are told that the price guidance has now been raised for all three tranches of notes from Aetna’s latest health care risk insurance-linked securities offering, while the target remains to secure $250 million of reinsurance from the Vitality Re XVII Ltd (Series 2026) deal.

Aetna, the health, medical and benefits insurance unit of CVS Health, has returned to the insurance-linked securities (ILS) market seeking $250 million of health care related reinsurance from a Vitality Re XVII Ltd (Series 2026) deal, which will become its seventeenth deal in the Vitality Re series.

Aetna, the health, medical and benefits insurance unit of CVS Health, has now finalised the details of its sixteenth health and medical benefit claim linked insurance-linked securities (ILS) deal, securing the targeted $250 million of reinsurance from the Vitality Re XVI Ltd (Series 2025) issuance and making it the largest Vitality Re deal yet.

Aetna, the health, medical and benefits insurance unit of CVS Health, is on-track to secure what will be the largest insurance-linked securities (ILS) issuance in its long-standing Vitality Re series, as the firm’s sixteenth transaction continued to target $250 million of reinsurance from the Vitality Re XVI Ltd (Series 2025) deal.

Aetna, the health, medical and benefits insurance unit of CVS Health, is back in the insurance-linked securities (ILS) market and seeking what could become its largest issuance in the long-standing Vitality Re series, as the firm’s sixteenth transaction launches with a target for $250 million of reinsurance from a Vitality Re XVI Ltd (Series 2025) […]

Aetna, the health, medical and benefits insurance unit of CVS Health, has now successfully secured the targeted lower pricing for its fifteenth Vitality Re health insurance catastrophe bond issuance, with the $200m of notes on offer from the Vitality Re XV Ltd (Series 2024) transaction now priced at the bottom of reduced guidance.

Aetna, the health, medical and benefits insurance unit of CVS Health, is now targeting reduced pricing for what will be its fifteenth Vitality Re health insurance catastrophe bond issuance, with spread guidance reduced for the $200m of reinsurance it hopes to receive from the Vitality Re XV Ltd (Series 2024) transaction.

Aetna, the health, medical and benefits insurance unit of CVS Health, has returned to the insurance-linked securities (ILS) market, to sponsor what will be its fifteenth Vitality Re health insurance catastrophe bond issuance, aiming for $200m of reinsurance from a Vitality Re XV Ltd (Series 2024) transaction.

Health, medical and benefit insurer Aetna’s new Vitality Re XIV Ltd (Series 2023) health insurance-linked securities (ILS) has now priced, with the multiples on offer to investors at or near historic highs for the long-standing series of health insurance linked catastrophe bond deals.